Wave Life Sciences WVE Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's increase (decrease) in other operating assets?
- Wave Life Sciences (WVE) reported increase (decrease) in other operating assets of $751K in Q1 2026.
- How has Wave Life Sciences's increase (decrease) in other operating assets changed year-over-year?
- Wave Life Sciences's increase (decrease) in other operating assets increased by 736.4% year-over-year, from -$118K to $751K.
- What is the long-term trend for Wave Life Sciences's increase (decrease) in other operating assets?
- Over 2 years (2021 to 2024), Wave Life Sciences's increase (decrease) in other operating assets has grown at a 208.9% compound annual growth rate (CAGR), from $338K to $3.23M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.